Net Cash Provided by (Used in) Operating Activities |
7.07K |
USD |
|
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-5.08K |
USD |
-126% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
4B |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
1.48B |
shares |
+148% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.99K |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
30.4K |
USD |
-33.8% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
6.88M |
USD |
+4.45% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
6.88M |
USD |
+4.45% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
2M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
22M |
USD |
-2.36% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
755K |
USD |
-18.9% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |